Cocrystal Pharma Stock Market Value
| COCP Stock | USD 1.64 0.03 1.80% |
| Symbol | Cocrystal |
Cocrystal Pharma Price To Book Ratio
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cocrystal Pharma. If investors know Cocrystal will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cocrystal Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.84) | Revenue Per Share | Quarterly Revenue Growth 0.269 | Return On Assets | Return On Equity |
The market value of Cocrystal Pharma is measured differently than its book value, which is the value of Cocrystal that is recorded on the company's balance sheet. Investors also form their own opinion of Cocrystal Pharma's value that differs from its market value or its book value, called intrinsic value, which is Cocrystal Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cocrystal Pharma's market value can be influenced by many factors that don't directly affect Cocrystal Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cocrystal Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cocrystal Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cocrystal Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cocrystal Pharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Cocrystal Pharma's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Cocrystal Pharma.
| 12/16/2024 |
| 03/16/2025 |
If you would invest 0.00 in Cocrystal Pharma on December 16, 2024 and sell it all today you would earn a total of 0.00 from holding Cocrystal Pharma or generate 0.0% return on investment in Cocrystal Pharma over 90 days. Cocrystal Pharma is related to or competes with RenovoRx, Tempest Therapeutics, Ikena Oncology, Moleculin Biotech, Pulmatrix, Cyclacel Pharmaceuticals, and Akari Therapeutics. Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treat... More
Cocrystal Pharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Cocrystal Pharma's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Cocrystal Pharma upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 7.63 | |||
| Information Ratio | 0.0269 | |||
| Maximum Drawdown | 62.44 | |||
| Value At Risk | (6.32) | |||
| Potential Upside | 14.85 |
Cocrystal Pharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cocrystal Pharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Cocrystal Pharma's standard deviation. In reality, there are many statistical measures that can use Cocrystal Pharma historical prices to predict the future Cocrystal Pharma's volatility.| Risk Adjusted Performance | 0.0216 | |||
| Jensen Alpha | 0.1335 | |||
| Total Risk Alpha | 1.11 | |||
| Sortino Ratio | 0.0283 | |||
| Treynor Ratio | 0.4409 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Cocrystal Pharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Cocrystal Pharma Backtested Returns
Currently, Cocrystal Pharma is dangerous. Cocrystal Pharma secures Sharpe Ratio (or Efficiency) of close to zero, which signifies that the company had a close to zero % return per unit of standard deviation over the last 3 months. We have found thirty technical indicators for Cocrystal Pharma, which you can use to evaluate the volatility of the firm. Please confirm Cocrystal Pharma's risk adjusted performance of 0.0216, and Mean Deviation of 4.64 to double-check if the risk estimate we provide is consistent with the expected return of 0.0199%. The firm shows a Beta (market volatility) of 0.24, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Cocrystal Pharma's returns are expected to increase less than the market. However, during the bear market, the loss of holding Cocrystal Pharma is expected to be smaller as well. Cocrystal Pharma right now shows a risk of 8.27%. Please confirm Cocrystal Pharma standard deviation, expected short fall, period momentum indicator, as well as the relationship between the maximum drawdown and rate of daily change , to decide if Cocrystal Pharma will be following its price patterns.
Auto-correlation | 0.57 |
Modest predictability
Cocrystal Pharma has modest predictability. Overlapping area represents the amount of predictability between Cocrystal Pharma time series from 16th of December 2024 to 30th of January 2025 and 30th of January 2025 to 16th of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Cocrystal Pharma price movement. The serial correlation of 0.57 indicates that roughly 57.0% of current Cocrystal Pharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.57 | |
| Spearman Rank Test | 0.46 | |
| Residual Average | 0.0 | |
| Price Variance | 0.02 |
Cocrystal Pharma lagged returns against current returns
Autocorrelation, which is Cocrystal Pharma stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Cocrystal Pharma's stock expected returns. We can calculate the autocorrelation of Cocrystal Pharma returns to help us make a trade decision. For example, suppose you find that Cocrystal Pharma has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Cocrystal Pharma regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Cocrystal Pharma stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Cocrystal Pharma stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Cocrystal Pharma stock over time.
Current vs Lagged Prices |
| Timeline |
Cocrystal Pharma Lagged Returns
When evaluating Cocrystal Pharma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Cocrystal Pharma stock have on its future price. Cocrystal Pharma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Cocrystal Pharma autocorrelation shows the relationship between Cocrystal Pharma stock current value and its past values and can show if there is a momentum factor associated with investing in Cocrystal Pharma.
Regressed Prices |
| Timeline |
Additional Tools for Cocrystal Stock Analysis
When running Cocrystal Pharma's price analysis, check to measure Cocrystal Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cocrystal Pharma is operating at the current time. Most of Cocrystal Pharma's value examination focuses on studying past and present price action to predict the probability of Cocrystal Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cocrystal Pharma's price. Additionally, you may evaluate how the addition of Cocrystal Pharma to your portfolios can decrease your overall portfolio volatility.